March 11 (E.U) - The Covid-19 vaccine developed by UK's Oxford University and AstraZeneca has run into trouble in some E.U countries as there are fears it may have caused blood-clots after administration of the vaccine.
Norway and Denmark have already suspended the use of Oxford-AstraZeneca vaccine. They did so after Austra suspended the use of a specific batch of the same vaccine because a patient was diagnosed with multiple thromboisis (blood clots) and died 10 days after getting the vaccination shot.
Italy has also ordered the withdrawal of a batch of same vaccine after the deaths of two patients. A 51 year old man in Italy has died after developing blood clots after taking the vaccine. However it is not yet clear whether it was the vaccine that caused the blood clot.
This is a big blow to the vaccine rollout plans in Europe. There are still two other vaccine candidates available from Pfizer and Moderna. All eyes are now fixed on the results of phase 3 data of the Covaxin Covid-19 vaccine developed by India's Bharat Biotech.
reporting for easykobo.com on Thursday, March 11 2021 from Lagos, Nigeria